申请人:Seachald Pharmaceuticals, Inc.
公开号:US20140171357A1
公开(公告)日:2014-06-19
The invention features vancomycin class compounds modified to be suitable for oral delivery or to possess increased antimicrobial potency, formulations for the oral administration of vancomycin class compounds, and synthetic methods for making vancomycin class compounds.